Evaluation of endotoxin activity in blood measured via neutrophil chemiluminescence in healthy horses and horses with colic

Judith B. Koenig Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by Judith B. Koenig in
Current site
Google Scholar
PubMed
Close
 Dr med vet, DVSc
,
James Hart Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by James Hart in
Current site
Google Scholar
PubMed
Close
 BVSc
,
David M. Harris Spectral Diagnostics Inc, 135 The West Mall, Toronto, ON M9C 1C2, Canada.

Search for other papers by David M. Harris in
Current site
Google Scholar
PubMed
Close
 BSc
,
Antonio M. Cruz Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by Antonio M. Cruz in
Current site
Google Scholar
PubMed
Close
 DVM, MVM, MSc, DrMedVet
, and
Dorothee Bienzle Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by Dorothee Bienzle in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To evaluate the performance of a chemiluminescent endotoxin activity assay in horses with colic and healthy horses.

Animals—20 horses with colic and systemic inflammatory response syndrome (SIRS group), 8 horses with colic with no SIRS (NSIRS group), and 20 healthy horses.

Procedures—Venous blood was collected into EDTA blood collection tubes after completion of a physical examination, and a chemiluminescent endotoxin activity assay was performed within 60 minutes of collection. Medical or surgical interventions and outcome were recorded for each horse.

Results—Mean ± SE endotoxin activity was 0.16 ± 0.05 for healthy horses, 0.18 ± 0.07 for the NSIRS group, and 0.53 ± 0.05 for the SIRS group and was significantly different among the groups. Mean endotoxin activity was significantly higher in the SIRS group than in the NSIRS group and the healthy group. No significant difference between the healthy and NSIRS groups was present. The higher the measured endotoxin activity, the more likely it was for horses to be euthanized.

Conclusions and Clinical Relevance—The chemiluminescent endotoxin assay was easy to use, required a short time to perform, could be completed at the patient's side, and with some modifications, may be a useful component in the clinical assessment and prognostication of horses with colic.

Abstract

Objective—To evaluate the performance of a chemiluminescent endotoxin activity assay in horses with colic and healthy horses.

Animals—20 horses with colic and systemic inflammatory response syndrome (SIRS group), 8 horses with colic with no SIRS (NSIRS group), and 20 healthy horses.

Procedures—Venous blood was collected into EDTA blood collection tubes after completion of a physical examination, and a chemiluminescent endotoxin activity assay was performed within 60 minutes of collection. Medical or surgical interventions and outcome were recorded for each horse.

Results—Mean ± SE endotoxin activity was 0.16 ± 0.05 for healthy horses, 0.18 ± 0.07 for the NSIRS group, and 0.53 ± 0.05 for the SIRS group and was significantly different among the groups. Mean endotoxin activity was significantly higher in the SIRS group than in the NSIRS group and the healthy group. No significant difference between the healthy and NSIRS groups was present. The higher the measured endotoxin activity, the more likely it was for horses to be euthanized.

Conclusions and Clinical Relevance—The chemiluminescent endotoxin assay was easy to use, required a short time to perform, could be completed at the patient's side, and with some modifications, may be a useful component in the clinical assessment and prognostication of horses with colic.

Contributor Notes

Dr. Hart's present address is Boren Veterinary Medical Teaching Hospital, Oklahoma State University, Stillwater, OK 74078.

Address correspondence to Dr. Koenig (jkoenig@uoguelph.ca).
  • 1.

    Moore JN, Barton MH. Treatment of endotoxemia. Vet Clin North Am Equine Pract 2003;19:681695.

  • 2.

    King JN, Gerring EL. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269271.

  • 3.

    Parsons CS, Orsini JA, Krafty R, et al. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997–2004). J Am Vet Med Assoc 2007;230:885889.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Barton MH, Morris DD, Norton N, et al. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J Vet Intern Med 1998;12:2635.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Barton MH, Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J Vet Intern Med 1999;13:457464.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Tamura H, Tanaka S, Obayashi T, et al. A new sensitive method for determining endotoxin in whole blood. Clin Chim Acta 1991;200:3542.

  • 7.

    Peek SF, Borah S, Semrad S, et al. Plasma endotoxin concentration in horses: a methods study. Vet Clin Pathol 2004;33:2931.

  • 8.

    Romaschin AD, Harris DM, Ribeiro MB, et al. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 1998;212:169185.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Marshall JC, Walker PM, Foster DM, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 2002;6:342348.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Kjelgaard-Hansen M, Wiinberg B, Aalbaek B, et al. Endotoxin activity in whole blood measured by neutrophil chemiluminescence is applicable to canine whole blood. Comp Immunol Microbiol Infect Dis 2008;31:477485.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Eades SC, Moore JN. Endotoxemia and endotoxemia. In: Auer JA, Stick JA, eds. Equine surgery. 3rd ed St Louis: Saunders Elsevier, 2006;920.

    • Search Google Scholar
    • Export Citation
  • 12.

    Romaschin AD, Walker PM. Endotoxin activity in whole blood by neutrophil chemiluminescence—a novel analytical paradigm. Clin Chem 2000;46:15041506.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Shoukri M, Pause C. Statistical analysis of cross classified data. In: Statistical methods for health sciences. 2nd ed Boca Raton, Fla: CRC Press, 1999;43143.

    • Search Google Scholar
    • Export Citation
  • 14.

    Fessler JF, Bottoms GD, Coppoc GL, et al. Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine Vet J Suppl 1989;7:2428.

    • Search Google Scholar
    • Export Citation
  • 15.

    Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190:527534.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement